[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-{[(2S,3R,4R,5S,6R)-5-{[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-10-{[(2R,5S,6S)-5-(dimethylamino)-6-methyltetrahydro-2H-pyra,13430-00-7;13441-34-4;1403-57-2;1405-25-0;24916-50-5;2517-38-6;50762-61-3;67262-35-5 Products Supply

Name: [(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-{[(2S,3R,4R,5S,6R)-5-{[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-10-{[(2R,5S,6S)-5-(dimethylamino)-6-methyltetrahydro-2H-pyra
CAS NO.: 13430-00-7;13441-34-4;1403-57-2;1405-25-0;24916-50-5;2517-38-6;50762-61-3;67262-35-5
Synonyms:
Foromacidine A;Spiramycin A;Spiramycin 1;Spiramycin I;Demycarosylturimycin H;spiramycin;Foromacidin;Leucomycin V, 9-O-((2R,5S,6R)-5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl)-;NSC55926;NSC64393;IC 5902;RP 5337;UNII-033ECH6IFG;AC1O5U2X;24916-50-5;8025-81-8;C43H74N2O14;LS-145761;Leucomycin V, 9-O-(5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl)-, (9(2R,5S,6R))-;13430-00-7;13441-34-4;1403-57-2;1405-25-0;2-[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[(2S,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2R,5S,6S)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde;2517-38-6;50762-61-3;67262-35-5;Leucomycin V, 9-O-(5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl)-, (9(2R,5S,6R))- (9CI)
Molecular Structure:
Molecular Formula: C₄₃H₇₄N₂O₁₄

Send a message direct to supplier(s)*

Please post your buying leads,so that our qualified suppliers will soon contact you!

CAS NO.：
* Purchase Request：

* Your Email：
* Name：
* Gender：	Male Female
* Country/Area：
* Company Name：
* Tel：	- - Country - Code Area - Code Number

* Message：

Related products: [(4R,5S,6S,7R,9R,10R,11E,13E,1; (4S,5S,6S,7R,9R,10R,11E,13E,16; (4S,5S,6S,7R,9R,10R,11E,13E,16; (4S,5S,6S,7R,9R,10R,11E,13E,16; potassium dihydrogen phosphate; (2S)-2-aminopentanedioic acid ; (4R,5S,6S,7R,9R,11E,13E,15S,16; (3R,4S,5S,6R,7R,9R,11R,12R,13S; (2R)-hydroxy[(2S,3S,4S,5S,6S)-; 4-amino-N-(4,6-dimethylpyrimid; 4-amino-N-(3,4-dimethyl-1,2-ox; 1-ethyl-7-methyl-4-oxo-1,4-dih; (2R,3S,4S,5R,6S)-5-(((2R,3R,4R; methyl (S)-2-((2S,5S,6S)-6-((2; (2R)-3-{[{[(2R,3R,4R,5S,6S)-3-; (2S)-4-{[(2R,3R,4R,5S,6R)-3-(a; (2S,3R,4S,6S)-6-{[(5Z,13E)-2-{; (3E,5E,7S,8S,11E,13E,15S,16S)-; (2R)-3-{[{[(2R,3R,4S,5R,6S)-3-; (2R)-3-{[{[(2R,3R,4S,5R,6S)-3-; (2R,4R)-4-((2S,5S,6S)-6-((S)-1; 10-[(2R,4S,5S,6S)-4-(dimethyla; (2S,4R,6E,8S)-8-[(2S,2'R,4'S,5; methyl (S)-2-((2S,5S,6S)-6-((2; sodium (2S,4R,6E,8S)-8-[(2S,2'; (2R,3R,4R,5R)-2,3,5,6-tetrahyd; (2R,3S,4S,5R,6R)-5-(((2R,3R,4R; [(2S,3R,4R,6S)-6-[(2R,3S,4R,5R; (2R,3S,4R,5R)-2,3,4,5-tetrahyd; 2H-Pyran-2-acetic acid,6-[[(2R;